Ref ID: 19500
Author:
K Diba1, K Makhdoomi2, A Namaki3*, D Jabbari1
Author address:
1Medical Mycology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
2Nephrology, Imam Educational Hospital, Urmia University of Medical Sciences, Urmia, Iran
3Surgery, Arefian General Hospital, Urmia, Iran
Full conference title:
6th Advances Against Aspergillosis 2014
Abstract:
Purpose:
The aim of this study was searching the frequent Aspergillus species causing hospital aquired
infections and the environmental sources for Aspergillus infectiions in hodpital indoors.
Methods:
The subject of our study included bronchial fluids and sputum were collected from the hospitalized
patients with acute respiratory symptoms. For the environmental study, some specimens were
collected from air and environment surfaces. A morphological study was firstly performed including;
growth characteristics and microscopic features of Aspergilus species on mycological media.
For the confirmation of Aspergilus isolates which similarly found in clinical and environmental
sources, PCR-restriction fragment lenght polymorphism using a novel restriction enzyme Mwo I
and the molecular technique of random amplified polymorphic DNA (RAPD) were carried out for
searching the hospital aspergilus sources.
Results:
Totally of 102 fungal isolates, including Candida species 82 (80%), Aspergillus spp.20 (19.6%)
and the other fungi 2 (0.4%). Among the clinical isolates, Aspergillus flavus (8.4%), Aspergillus
fumigatus (4.2%) and Aspergillus niger (2.8%) were identified, as well as environmental Aspergillus
isolates Aspergillus flavus (19.4%), Aspergillus niger (6.5%) and Aspergillus fumigatus (6.5%).
Conclusion:
Comparing the clinical and environmental findings, 2 of 11 clinical Aspergillus isolates were matched
with environmental isolates from ventilation systems and wall surfaces, using RAPD but the other
environmental sources were not confirmed.
Abstract Number: 28
Conference Year: 2014
Link to conference website: http://www.AAA2014.org
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a